Biopharma Is The Pinnacle Of Invention Which Drives Growth

Rising prices, the Fed raising rates, and supply chain bottlenecks are all factors driving market uncertainty, says Louise Goudy Willmering. She discusses her sector picks which include healthcare and consumer staples. She is very interested in large biopharmaceutical companies, as healthcare stocks are the pinnacle of invention which helps drive growth. She also highlights the Select Sector SPDR Trust SBI Healthcare ETF (XLV). She also talks about how demand for consumer staples has been strong, but many products are still not on the shelves. Tune in to find out more.